Related references
Note: Only part of the references are listed.Elevated Circulating Endocan Levels Are Associated with Increased Levels of Endothelial and Inflammation Factors in Postprandial Lipemia
Serap Ozer Yaman et al.
JOURNAL OF CLINICAL MEDICINE (2023)
Endocan: A Key Player of Cardiovascular Disease
Jinzhi Chen et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Cheng-Xu Ma et al.
CARDIOVASCULAR DIABETOLOGY (2022)
The Underlying Pathology of Atherosclerosis: Different Players
Noemi Rotllan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes
Alejandra Planas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology
Peter Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Increased endocan expression as a biomarker of endothelial dysfunction in patients with metabolic syndrome
Sylwia Iwanczyk et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2022)
SERUM ENDOCAN LEVELS IN RELATION TO TRADITIONAL AND NON-TRADITIONAL ANTHROPOMETRIC INDICES IN ADULT POPULATION
Aleksandra Klisic et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2021)
Cardiovascular Biomarkers and Calculated Cardiovascular Risk in Orally Treated Type 2 Diabetes Patients: Is There a Link?
Aleksandra Markova et al.
HORMONE AND METABOLIC RESEARCH (2021)
Increased Carotid Intima-Media Thickness and Endothelial Cell-Specific Molecule-1 (Endocan) Levels in Obese Children
Aysin Nalbantoglu et al.
ANGIOLOGY (2021)
Cardiovascular risk assessment and association with novel biomarkers in patients with Type 2 diabetes mellitus
Ane K. M. Neri et al.
BIOMARKERS IN MEDICINE (2021)
Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus
M. Resl et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
Cosmin Mihai Vesa et al.
DIAGNOSTICS (2020)
Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes
Aleksandra Klisic et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
IS ENDOCAN A NOVEL POTENTIAL BIOMARKER OF LIVER STEATOSIS AND FIBROSIS?
Aleksandra Klisic et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2020)
Metformin Effect on Endocan Biogenesis in Human Endothelial Cells Under Diabetic Condition
Elmira Zolali et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations
Sheng Qian Yew et al.
ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH (2019)
Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension
Sevil Fisekci Oktar et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2019)
Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
Nebojsa Kavaric et al.
OPEN MEDICINE (2018)
Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes
Katherine N. Bachmann et al.
DIABETOLOGIA (2018)
Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
Ekaterina A. Ivanova et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population
Dipika Bansal et al.
DIABETES & METABOLISM JOURNAL (2015)
Comparison of the Framingham Risk Score, UK Prospective Diabetes Study (UKPDS) Risk Engine, Japanese Atherosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC) and Maximum Carotid Intima-Media Thickness for Predicting Coronary Artery Stenosis in Patients with Asymptomatic Type 2 Diabetes
Kazuya Fujihara et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In Vivo
Wonhwa Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society
Marcello Casaccia Bertoluci et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus
J.-B. Echouffo-Tcheugui et al.
DIABETES & METABOLISM (2013)
UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
A. J. Hayes et al.
DIABETOLOGIA (2013)
The Effects of Arterial Blood Pressure Reduction on Endocan and Soluble Endothelial Cell Adhesion Molecules (CAMs) and CAMs Ligands Expression in Hypertensive Patients on Ca-Channel Blocker Therapy
Refmir Tadzic et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2013)
Is It LDL Particle Size or Number that Correlates with Risk for Cardiovascular Disease?
H. Robert Superko et al.
CURRENT ATHEROSCLEROSIS REPORTS (2008)
UKPDS 60 - Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
V Kothari et al.
STROKE (2002)
Share Paper
